Introduction/Background ERAS guideline 2019 outlines the most current recommendations of the ERAS Society Group for the perioperative management of patients undergoing gynaecologic/oncology surgery, and is based on the best available evidence. The primary clinical benefits of implementing these protocols are shorter hospital, length of stay and reduced post-operative complications (including respiratory complications) in low, medium and high complexity gynaecologic oncology surgeries. In view of the above facts, the present study is planned to study the influence of implementation of ERAS protocol on postoperative recovery and outcome in gynaecologic oncology patients.

Methodology The study population comprises of all gynaecology oncology patients more than 18 years of age who undergo laparotomy with a provisional or proven diagnosis of cancer of the uterus, cervix or ovary. The patients were randomized in two groups by block randomization: Group E- ERAS protocol and Group C- Conventional protocol The following measures were taken for Group E patients: preoperative bathing.no preoperative sedative medication, preoperative antibiotic within 60 minutes of incision, no long-acting opioids, no drains or nasogastric tube, compression stockings postoperatively, low molecular weight heparin given postoperatively, use of chewing gum in postoperative phase, mobilization on day of surgery. The outcome measures include duration of hospital stay, readmission within 21 days, time taken for return of bowel function, rate of postoperative ileus and incidence of surgical site infections.

Results 30 patients were included in Group E and Group C each. The duration of hospital stay, rate of postoperative ileus and incidence of surgical site infections were significantly decreased in the ERAS group.

Conclusion ERAS protocol has a significant beneficial effect on perioperative outcomes in Gynaecologic oncology patients.